At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

Job Summary:
Global Pharmacokinetics/Pharmacodynamics (PK/PD) and Pharmacometrics Department at Lilly is seeking a highly motivated scientist to join our dynamic team of clinicians and researchers in Singapore. This position will be responsible for developing innovative methods for assessing drug efficacy and safety in humans through translational medicine approaches using advanced biomarker techniques such as multiplex immunoassays and mass spectrometry imaging technologies. The successful candidate will have the opportunity to work on diverse therapeutic areas including Cardiometabolic Health, Oncology, Immunology and Neuroscience, and contribute to clinical trials across all phases. The individual should possess strong scientific acumen, excellent communication skills, be able to effectively interact with cross-functional teams, and demonstrate high flexibility in managing competing priorities.

Responsibilities:

Provide PK/PD/Pharmacometric and scientific analysis under guidance of project leader to support the selection of the right target, molecule, dose, patient population, and development strategies. You will apply the appropriate PK/PD and pharmacometric approaches to translate from preclinical to the clinical setting by integrating data from multiple teams.Be able to identify and troubleshoot scientific/operational questions or issues and develop effective solutions to advance the portfolio.Support decision-making through collaboration on cross-functional teams.Support the preparation and timely delivery of Phase I, II, and III study protocols, analysis plans, data analysis and interpretation, study reports and disclosures.Assist in the preparation of relevant INDs, IBs, CTDs and other regulatory documents for development and registration of new drugs and line extensions across multiple geographies. This may include interactions with FDA, EMA, PMDA and other regulatory agencies.Participate in shared learning with other scientists within the department and in other areas as well as interact, teach and collaborate with academia to stay current with external environment.

Qualifications:
- Bachelor’s degree in Biological Science, Chemistry, Biochemistry, Analytical Chemistry, or equivalent experience required
- Master’s degree preferred but not mandatory
- Excellent understanding of clinical pharmacology (PK, PD and pharmacometrics) principles.

- 2-3 years experience from industry is preferred.

- Candidates with working knowledge of NONMEM, R, WinNonlin, Monolix will be much desired.

- Knowledgeable in clinical trial processes and Good Clinical Practice guidelines
- Excellent verbal and written English communication skills; additional language skillsets are advantageous
- Proficiency with Microsoft Office applications (Word, Excel, PowerPoint, Outlook)
 

Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form (https://careers.lilly.com/us/en/workplace-accommodation) for further assistance. Please note this is for individuals to request an accommodation as part of the application process and any other correspondence will not receive a response.

Lilly does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability or any other legally protected status.

#WeAreLilly